Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA064454-03
Application #
2106937
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1994-08-01
Project End
1999-07-31
Budget Start
1996-08-01
Budget End
1997-07-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Kulu, Y; Kawasaki, H; Donahue, J M et al. (2013) Concurrent chemotherapy inhibits herpes simplex virus-1 replication and oncolysis. Cancer Gene Ther 20:133-40
Kasuya, Hideki; Pawlik, Timothy M; Mullen, John T et al. (2004) Selectivity of an oncolytic herpes simplex virus for cells expressing the DF3/MUC1 antigen. Cancer Res 64:2561-7
Pawlik, Timothy M; Nakamura, Hideo; Mullen, John T et al. (2002) Prodrug bioactivation and oncolysis of diffuse liver metastases by a herpes simplex virus 1 mutant that expresses the CYP2B1 transgene. Cancer 95:1171-81
Nakamura, Hideo; Kasuya, Hideki; Mullen, John T et al. (2002) Regulation of herpes simplex virus gamma(1)34.5 expression and oncolysis of diffuse liver metastases by Myb34.5. J Clin Invest 109:871-82
Pawlik, T M; Nakamura, H; Yoon, S S et al. (2000) Oncolysis of diffuse hepatocellular carcinoma by intravascular administration of a replication-competent, genetically engineered herpesvirus. Cancer Res 60:2790-5
Choi, S H; Takahashi, K; Eto, H et al. (2000) CD44s expression in human colon carcinomas influences growth of liver metastases. Int J Cancer 85:523-6
Yoon, S S; Nakamura, H; Carroll, N M et al. (2000) An oncolytic herpes simplex virus type 1 selectively destroys diffuse liver metastases from colon carcinoma. FASEB J 14:301-11
Eto, H; Yoon, S S; Bode, B P et al. (2000) Mapping and regulation of the tumor-associated epitope recognized by monoclonal antibody RS-11. J Biol Chem 275:27075-83
Yoon, S S; Carroll, N M; Chiocca, E A et al. (1999) Influence of p53 on herpes simplex virus type 1 vectors for cancer gene therapy. J Gastrointest Surg 3:34-48
Yoon, S S; Eto, H; Lin, C M et al. (1999) Mouse endostatin inhibits the formation of lung and liver metastases. Cancer Res 59:6251-6

Showing the most recent 10 out of 21 publications